<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00279591</url>
  </required_header>
  <id_info>
    <org_study_id>48082</org_study_id>
    <secondary_id>CUMG Grant</secondary_id>
    <nct_id>NCT00279591</nct_id>
  </id_info>
  <brief_title>Near-Continuous, Noninvasive Blood Pressure Monitoring to Improve Outcomes in Pediatric Transport</brief_title>
  <official_title>Near-Continuous, Noninvasive Blood Pressure Monitoring to Improve Outcomes in Pediatric Transport</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled trial compared the clinical outcomes of transported pediatric
      patients monitored with an oscillometric blood pressure device versus those monitored with a
      near-continuous, noninvasive blood pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      94 transported patients were randomized to a control arm, monitored with a standard
      oscillometric blood pressure device (Dinamap), or an experimental arm, monitored with a
      near-continuous, noninvasive blood pressure device (Vasotrac).
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of technical support and supplies
  </why_stopped>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Difference in Hospital Length of Stay Between Those Who Received Continuous Blood Pressure Monitoring and Those Who Received Standard of Care</measure>
    <time_frame>Up to two weeks</time_frame>
    <description>This is the total number of participants analyzed for the intervention group and the total number of participants analyzed for the control group and the total number of days that each group was analyzed overall.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit (ICU) Length of Stay</measure>
    <time_frame>Up to two weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Number of Organ Failure Days (Multiple Organ Dysfunction) in the Intensive Care Unit (ICU)for the Control Group and Total Number of Organ Failure Days for the Intervention Group. Multiple Organ Dysfunction is Defined as Multiple Organ Failure.</measure>
    <time_frame>Up to two weeks</time_frame>
    <description>Total number of organ failure days is for each group as a whole.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Daily Score Using the Therapeutic Intervention Scoring System (TISS-28) Scale.</measure>
    <time_frame>Up to two weeks</time_frame>
    <description>The Therapeutic Intervention Scoring System (TISS-28) is an illness severity score for the ICU. The TISS score can range from zero up to 78. The higher the score is, the more severe the illness. The TISS-28 scale measures the severity of a patient's illness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Intravenous Fluid Resuscitation</measure>
    <time_frame>At start of inter-facility transport, then every 15 minutes until arrival.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Pediatric Patients With SIRS (Systemic Inflammatory Response Syndrome)</condition>
  <arm_group>
    <arm_group_label>Continuous Blood Pressure Monitoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received continuous blood pressure monitoring the entire time they were in med flight to the hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care blood pressure monitoring</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients received the normal standard of care for blood pressure monitoring during the course of the med flight to the hospital.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous blood pressure monitoring using (Dinamap) standard oscillometric blood pressure device</intervention_name>
    <description>Continuous blood pressure monitoring of patients during med flight to hospital</description>
    <arm_group_label>Continuous Blood Pressure Monitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard of care blood pressure monitoring</intervention_name>
    <description>Patients received the standard of care for blood pressure monitoring while en route to the hospital via med flight.</description>
    <arm_group_label>Standard of care blood pressure monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Pediatric patients transported by Angel One to Arkansas Children's Hospital.

          2. Age Group: 1 year - 17 years AND

          3. Patients at risk of developing SIRS (Systemic Inflammatory Response Syndrome),
             according to the criteria below.

             i. The presence of at least two of the following four criteria (one of which must be
             abnormal temperature or leukocyte count): A. Core temperature of &gt;38.5 C or &lt;36 C. B.
             Tachycardia, defined as mean heart rate &gt;95th percentile for age in absence of
             external stimulus, chronic drugs, or painful stimuli.

             C. Mean respiratory rate &gt;95th percentile for age, or &gt;10% immature neutrophils.

             OR

          4. Patients with moderate or severe head trauma, at risk of developing secondary ischemic
             brain injury, according to the criteria below.

             i. Glasgow Coma scale &lt;15 with one or more of the following: A. Mass lesion or
             cerebral edema on CT or MRI scan. B. Post-Traumatic Seizure. C. Multiple Trauma. D.
             Focal Neurologic Signs. E. Intubation for control of suspected intracranial
             hypertension.

        Exclusion Criteria:

          1. Wrist circumference less than 11cm (minimum size for the Vasotrac device).

          2. Contractures of the wrists, not allowing correct placement of the Vasotrac device.

          3. Hematoma(s) located on both wrists from recent redial (&lt;24hr) artery puncture.

          4. Patients likely to proceed to brain death per assessment of the referring physician.

          5. Patients being treated for malignant hypertension.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Stroud, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Stroud MH, Prodhan P, Moss M, Fiser R, Schexnayder S, Anand K. Enhanced monitoring improves pediatric transport outcomes: a randomized controlled trial. Pediatrics. 2011 Jan;127(1):42-8. doi: 10.1542/peds.2010-1336. Epub 2010 Dec 20.</citation>
    <PMID>21173006</PMID>
  </results_reference>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2006</study_first_submitted>
  <study_first_submitted_qc>January 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2006</study_first_posted>
  <results_first_submitted>March 28, 2011</results_first_submitted>
  <results_first_submitted_qc>April 3, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 30, 2012</results_first_posted>
  <last_update_submitted>April 3, 2012</last_update_submitted>
  <last_update_submitted_qc>April 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Pediatric interfacility helicopter transport patients between May 2006 and June 2007.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>Oscillometric Blood Pressure Monitoring</description>
        </group>
        <group group_id="P2">
          <title>Intervention Group</title>
          <description>Near Continuous Blood Pressure Monitoring</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>Oscillometric Blood Pressure Monitoring</description>
        </group>
        <group group_id="B2">
          <title>Intervention Group</title>
          <description>Near Continuous Blood Pressure Monitoring</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="46"/>
            <count group_id="B3" value="94"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.5" spread="5.6"/>
                    <measurement group_id="B2" value="6.5" spread="4.6"/>
                    <measurement group_id="B3" value="7.5" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Difference in Hospital Length of Stay Between Those Who Received Continuous Blood Pressure Monitoring and Those Who Received Standard of Care</title>
        <description>This is the total number of participants analyzed for the intervention group and the total number of participants analyzed for the control group and the total number of days that each group was analyzed overall.</description>
        <time_frame>Up to two weeks</time_frame>
        <population>Intention to Treat</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Oscillometric Blood Pressure Monitoring</description>
          </group>
          <group group_id="O2">
            <title>Intervention Group</title>
            <description>Near Continuous Blood Pressure Monitoring</description>
          </group>
        </group_list>
        <measure>
          <title>The Difference in Hospital Length of Stay Between Those Who Received Continuous Blood Pressure Monitoring and Those Who Received Standard of Care</title>
          <description>This is the total number of participants analyzed for the intervention group and the total number of participants analyzed for the control group and the total number of days that each group was analyzed overall.</description>
          <population>Intention to Treat</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0" spread="13.8"/>
                    <measurement group_id="O2" value="5.4" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intensive Care Unit (ICU) Length of Stay</title>
        <time_frame>Up to two weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Oscillometric Blood Pressure Monitoring</description>
          </group>
          <group group_id="O2">
            <title>Intervention Group</title>
            <description>Near Continuous Blood Pressure Monitoring</description>
          </group>
        </group_list>
        <measure>
          <title>Intensive Care Unit (ICU) Length of Stay</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="4.5"/>
                    <measurement group_id="O2" value="2.8" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Number of Organ Failure Days (Multiple Organ Dysfunction) in the Intensive Care Unit (ICU)for the Control Group and Total Number of Organ Failure Days for the Intervention Group. Multiple Organ Dysfunction is Defined as Multiple Organ Failure.</title>
        <description>Total number of organ failure days is for each group as a whole.</description>
        <time_frame>Up to two weeks</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Organ Failure Days (Multiple Organ Dysfunction) in the Intensive Care Unit (ICU)for the Control Group and Total Number of Organ Failure Days for the Intervention Group. Multiple Organ Dysfunction is Defined as Multiple Organ Failure.</title>
          <description>Total number of organ failure days is for each group as a whole.</description>
          <population>ITT</population>
          <units>Days</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Days</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="206"/>
                <count group_id="O2" value="202"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Daily Score Using the Therapeutic Intervention Scoring System (TISS-28) Scale.</title>
        <description>The Therapeutic Intervention Scoring System (TISS-28) is an illness severity score for the ICU. The TISS score can range from zero up to 78. The higher the score is, the more severe the illness. The TISS-28 scale measures the severity of a patient's illness.</description>
        <time_frame>Up to two weeks</time_frame>
        <population>This is the total number of participants analyzed for the intervention group and the control group and the total number of days analyzed overall for the intervention group and the control group.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
          </group>
        </group_list>
        <measure>
          <title>Mean Daily Score Using the Therapeutic Intervention Scoring System (TISS-28) Scale.</title>
          <description>The Therapeutic Intervention Scoring System (TISS-28) is an illness severity score for the ICU. The TISS score can range from zero up to 78. The higher the score is, the more severe the illness. The TISS-28 scale measures the severity of a patient's illness.</description>
          <population>This is the total number of participants analyzed for the intervention group and the control group and the total number of days analyzed overall for the intervention group and the control group.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Days</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="206"/>
                <count group_id="O2" value="202"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.4" spread="10.1"/>
                    <measurement group_id="O2" value="23.9" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount of Intravenous Fluid Resuscitation</title>
        <time_frame>At start of inter-facility transport, then every 15 minutes until arrival.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Oscillometric Blood Pressure Monitoring</description>
          </group>
          <group group_id="O2">
            <title>Intervention Group</title>
            <description>Near Continuous Blood Pressure Monitoring</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Intravenous Fluid Resuscitation</title>
          <units>ml/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.8" spread="22.2"/>
                    <measurement group_id="O2" value="9.9" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>Oscillometric Blood Pressure Monitoring</description>
        </group>
        <group group_id="E2">
          <title>Intervention Group</title>
          <description>Near Continuous Blood Pressure Monitoring</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small Sample Size. Halted prior to projected enrollment secondary to lack of technical support and supplies for near continuous BP measuring device.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Michael Stroud</name_or_title>
      <organization>University of Arkansas for Medical Sciences</organization>
      <phone>501-364-1861</phone>
      <email>StroudMichaelH@uams.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

